Ledyard National Bank Biogen Inc. Transaction History

Ledyard National Bank

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 12, 2019	SELL	$216.71 - $338.96 $1.89 Million - $2.96 Million	-8,738 Closed	0 $0
Q4 2018 Jan 29, 2019	BUY	$278.5 - $352.75 $186,873 - $236,695	671 Added 8.32%	8,738 $2.63 Million
Q3 2018 Oct 24, 2018	SELL	$293.51 - $383.83 $3,228 - $4,222	-11 Reduced 0.14%	8,067 $2.85 Million
Q2 2018 Jul 11, 2018	BUY	$257.52 - $306.91 $8,240 - $9,821	32 Added 0.4%	8,078 $2.35 Million
Q1 2018 Apr 16, 2018	BUY	$260.13 - $367.91 $84,021 - $118,834	323 Added 4.18%	8,046 $2.2 Million
Q4 2017 Jan 30, 2018	SELL	$307.64 - $344.58 $80,601 - $90,279	-262 Reduced 3.28%	7,723 $2.46 Million
Q3 2017 Oct 10, 2017	BUY	$281.15 - $329.69 $2.24 Million - $2.63 Million	7,985	7,985 $2.5 Million

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Ledyard National Bank, based on Form 13F filings with the SEC.

Stay updated on Ledyard National Bank with notifications on news.